Adia Med Inc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ADIA | ACHC | HCA | ADIL | ACET | ACH | |
|---|---|---|---|---|---|---|
| Market cap | 5.85M | 3.00B | 106.68B | 13.26M | 29.02M | 21.18M |
| P/E (TTM) | — | — | 16.9 | — | — | — |
| Forward P/E | — | 17.5 | 16.3 | -0.7 | -0.8 | 3.2 |
| Price/book | -10.3 | 1.5 | -13.3 | -0.3 | 0.3 | 0.0 |
| Dividend yield | — | — | 0.61% | — | — | — |
| 1-year change | +106.67% | +59.18% | +8.35% | −50.46% | −71.38% | −91.03% |
| Today | −47.46% | +8.88% | +10.34% | +36.12% | −2.21% | −2.62% |
The closest companies by business and industry (Medical Care Facilities). Prices may be delayed up to 15 min.
Latest news
All ADIA news ›Adia Med sells Adia Labs units to CEO for $350K
Edible Garden Announces Commercial Supply Agreement and Strategic Partnership with Caney Fork Farms Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral…
Adia Med Finds Another Unicorn
CEO Larry Powalisz Spotlights Dr. Lyday, a Leading Stem Cell Champion, in New Podcast. Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today…
Adia Med sells 30% of Adia Labs for $1.5M
ADIA and the buyer each hold half the voting power despite different unit ownership, while economic rights remain tied to units. The sold units secure the buyer’s five-hundred-thousand-dollar note, giving ADIA a pledge remedy after notice…
Adia Med repays $935K credit line owed to CEO
The related-party credit facility carried 6% annual interest calculated daily before it was paid in full. The facility was entered into on June 30, 2024, with Powalisz as lender and the company and its relevant subsidiaries, as applicable,…
Adia Med Sells 30% of Adia Labs to QCM Biologics for $1.5 Million; Note and Option Included
TradingView Adia Med Sells 30% of Adia Labs to QCM Biologics for $1.5 Million; Note and Option Included Adia Med entered into a Membership Interest Purchase Agreement to sell 30% of Adia Labs to QCM Biologic
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
- enterpriseam.com1
- markets.financialcontent.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.